This is a multi-center phase Ib sutdy, which evaluates the safety and efficacy of lacutamab monotherpy in patients with relapse peripheral T-cell lymphoma that express KIR3DL2.
Age: 18 years - 66+
Gender: All
We've found 1 total result for "Lymphoma TCell".